Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Indian Patent Office proposes updation of guidelines for pharma patent examination
Indian Patent Office proposes updation of guidelines for pharma patent examination
BusinessLine

The Indian Patent Office (IPO) has proposed updating guidelines for examination of pharmaceutical patent applications to improve the quality, consistency and uniformity of scrutiny, taking into account the evolving interpretation of laws by courts.

marketbeat.com - Royalty Pharma PLC $RPRX Shares Sold by National Pension Service
Royalty Pharma PLC $RPRX Shares Sold by National Pension Service
MarketBeat

National Pension Service reduced its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 707,178…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Shares Purchased by California State Teachers Retirement System
BridgeBio Pharma, Inc. $BBIO Shares Purchased by California State Teachers Retirement System
MarketBeat

California State Teachers Retirement System increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 7,463.2% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 12,532,377…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Shares Sold by Tidal Investments LLC
BridgeBio Pharma, Inc. $BBIO Shares Sold by Tidal Investments LLC
MarketBeat

Tidal Investments LLC cut its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 17.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 106,980…

marketbeat.com - Tidal Investments LLC Has $6.63 Million Holdings in Royalty Pharma PLC $RPRX
Tidal Investments LLC Has $6.63 Million Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Tidal Investments LLC raised its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 298.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 118,323 shares of the…

cnbc.com - Evelyn Cheng - Goldman picks China healthcare stocks for a post-AI trade
Goldman picks China healthcare stocks for a post-AI trade
CNBC

Chinese corporate earnings are on a tear, giving investors clues on which stock sectors offer untapped returns, according to Goldman Sachs. Nearly half of MSCI China index constituents beat estimates in the second quarter, with IT and healthcare…

marketbeat.com - California State Teachers Retirement System Grows Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
California State Teachers Retirement System Grows Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
MarketBeat

California State Teachers Retirement System boosted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 3,376.3% in the second quarter, according to the company in its most recent 13F filing with the…

247wallst.com - Chris Lange - How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
24/7 Wall St

The exercise is simple: how large a position in Bristol Myers Squibb (NYSE:BMY | BMY Price Prediction) do you need to throw off $10,000 a year in dividend income? Start with the income target and solve backward, using the live yield and the live…

menshealth.com - Gregory Scott Brown, MD - The War On Antidepressants Has Officially Arrived
The War On Antidepressants Has Officially Arrived
Men's Health

A FEW MONTHS ago, when the morning news was first talking about how HHS Secretary Robert F. Kennedy, Jr. had announced plans to curb “psychiatric overprescribing,” I immediately thought of my patients. I often do before the sun begins…

marketbeat.com - Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen
Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen
MarketBeat

Pfizer (NYSE:PFE - Get Free Report) was upgraded by analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a note issued to investors on Sunday, Wall Street Zen reports. The Phase 3 Failure That Sent Biotech Winners and Losers in…

marketbeat.com - California State Teachers Retirement System Purchases 8,356,007 Shares of Lantheus Holdings, Inc. $LNTH
California State Teachers Retirement System Purchases 8,356,007 Shares of Lantheus Holdings, Inc. $LNTH
MarketBeat

California State Teachers Retirement System grew its position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH - Free Report) by 10,684.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange…

marketbeat.com - VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.45 Million in Teladoc Health, Inc. $TDOC
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.45 Million in Teladoc Health, Inc. $TDOC
MarketBeat

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…

marketbeat.com - Squarepoint Ops LLC Buys 155,556 Shares of Schrodinger, Inc. $SDGR
Squarepoint Ops LLC Buys 155,556 Shares of Schrodinger, Inc. $SDGR
MarketBeat

Squarepoint Ops LLC increased its stake in shares of Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 290.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The…

marketbeat.com - National Pension Service Increases Stock Holdings in DexCom, Inc. $DXCM
National Pension Service Increases Stock Holdings in DexCom, Inc. $DXCM
MarketBeat

National Pension Service boosted its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 660,309 shares of the medical device company's stock…

marketbeat.com - AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
MarketBeat

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Astrazeneca NYSE: AZN presented Phase III data for tozorakimab in chronic obstructive pulmonary disease, or COPD, at the 2026 European Respiratory Society Congress in…

Receive a Daily briefing on Pharma Industry News

Get Started